A PIM-1 Kinase Inhibitor Docking Optimization Study Based on Logistic Regression Models and Interaction Analysis
Life · 27.07.2023 · 13 (8) · 1635
DOI: 10.3390/life13081635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 27.07.2023. Verfasst von George Nicolae Daniel Ion und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Net4SCIENCE: Applied doctoral and postdoctoral research network in the fields of smart specialization Health and Bioeconomy”.
Abstract (Originalsprache)
PIM-1 kinase is a serine-threonine phosphorylating enzyme with implications in multiple types of malignancies, including prostate, breast, and blood cancers. Developing better search methodologies for PIM-1 kinase inhibitors may be a good strategy to speed up the discovery of an oncological drug approved for targeting this specific kinase. Computer-aided screening methods are promising approaches for the discovery of novel therapeutics, although certain limitations should be addressed. A frequent omission that is encountered in molecular docking is the lack of proper implementation of scoring functions and algorithms on the post-docking results, which usually alters the outcome of the virtual screening. The current study suggests a method for post-processing docking results, expressed either as binding affinity or score, that considers different binding modes of known inhibitors to the studied targets while making use of in vitro data, where available. The docking protocol successfully discriminated between known PIM-1 kinase inhibitors and decoy molecules, although binding energies alone were not sufficient to ensure a successful prediction. Logistic regression models were trained to predict the probability of PIM-1 kinase inhibitory activity based on binding energies and the presence of interactions with identified key amino acid residues. The selected model showed 80.9% true positive and 81.4% true negative rates. The discussed approach can be further applied in large-scale molecular docking campaigns to increase hit discovery success rates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania.
ORCID-Profile: George Nicolae Daniel Ion, George Mihai Nitulescu, Dragos Paul Mihai
Förderung
- “Net4SCIENCE: Applied doctoral and postdoctoral research network in the fields of smart specialization Health and Bioeconomy”
Zitieren
APA
Ion, G. N. D., Nitulescu, G. M., & Mihai, D. P. (2023). A PIM-1 Kinase Inhibitor Docking Optimization Study Based on Logistic Regression Models and Interaction Analysis. Life, 13(8), 1635. https://doi.org/10.3390/life13081635
Vancouver
Ion GND, Nitulescu GM, Mihai DP. A PIM-1 Kinase Inhibitor Docking Optimization Study Based on Logistic Regression Models and Interaction Analysis. Life. 2023;13(8):1635. doi:10.3390/life13081635
BibTeX
@article{Ion2023,
author = {Ion, George Nicolae Daniel and Nitulescu, George Mihai and Mihai, Dragos Paul},
title = {A PIM-1 Kinase Inhibitor Docking Optimization Study Based on Logistic Regression Models and Interaction Analysis},
journal = {Life},
year = {2023},
volume = {13},
number = {8},
pages = {1635},
doi = {10.3390/life13081635}
}
EUVIMED